How the ACA’s Tax Provisions Affect the Medical Device Sector: Johnson & Johnson (JNJ), Medtronic, Inc. (MDT), St. Jude Medical, Inc. (STJ)

Page 1 of 2

This article is brief look at the medical device excise tax under the Affordable Care Act and its affect on medical device companies.

The $20 billion tax went into play on January 1. That figure is based on a 2.3 percent tax being levied on the total revenues of a medical device company whether or not the outfit generates a profit. According to the Medical Device Manufacturer’s Association (MDMA), some device outfits will owe more in taxes than the revenue generated from their operations.

In sum, the MDMA contends the tax will “stifle innovation, harm patient care and weaken the position of the United States as the global leader in medical device innovation.” However, the Association’s claim is arguable. Recent financial reporting of the top outfits in this sector offer no evidence that business is suffering.

Johnson & Johnson (NYSE:JNJ)The list of top medical device manufacturers includes Johnson & Johnson (NYSE:JNJ), Medtronic, Inc. (NYSE:MDT) and St. Jude Medical, Inc. (NYSE:STJ).

is a leader in pharmaceutical and consumer packaged goods and medical devices. In January, Johnson & Johnson (NYSE:JNJ) reported better than expected Q4 2012 earnings of $2.6 billion or 91 cents per share eventhough total sales of $17.56 billion fell short of the Street’s expectation of $17.7 billion. However, some analysts note sales were off only for the consumer goods (band-aids, shampoos and such). And the improved earnings resulted from better sales of prescription drugs and demand for its medical devices.

Whether such demand will be affected by the excise tax is unclear. But the company’s $20 billion acquisition of Swiss orthopedics giant Synthes in 2012 put Johnson & Johnson (NYSE:JNJ) ahead of the game. The acquisition accounted for almost 8% of the device units’ revenue growth in 2012.

The real challenge for Johnson & Johnson (NYSE:JNJ) is product liability cases connected to problems with artificial hip replacements. Over the weekend, a Los Angeles jury began deliberations over a faulty hip implant. This is the first case to go to trial in a wave of legal actions connected to its metal-on-metal device. Johnson & Johnson (NYSE:JNJ) also recently lost a lawsuit over the failure of a trans-vaginal surgical mesh device. Last week a New Jersey jury awarded a woman $3.35 million in compensatory damages as well as $7.76 million in punitive damages.

There are about 1,800 similar cases facing the company. This might lead to rewards in the billions. In short, these suits are a far greater challenge than the excise tax.

is the world’s largest medical technology company offering a wide range of medical therapies for treating cardio-vascular diseases, diabetes and neurological disorders.

For the quarter ended January 25, Medtronic, Inc. (NYSE:MDT) reported a profit of $988 million, or 97 cents a share, up from $935 million, or 88 cents a share, a year earlier. Further, adjusted earnings from continuing operations climbed to 93 cents from 84 cents while revenue increased 2.8 percent to $4.03 billion (an increase of  4 percent). Medtronic, Inc. (NYSE:MDT)’s fiscal third-quarter earnings rose 5.7 percent as it reported stronger revenue despite soft markets for some spine and heart products.

In particular, sales of defibrillators (which shock hearts to stop potentially fatal rhythm distortions) have faced enhanced government scrutiny by the FDA over implant practices. But the company showed stronger performance is other areas such as neuro-modulation, and catheter-delivered heart valves to lift overall corporate growth.

Page 1 of 2

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The World’s Most Famous Circuses

Best Hair Stylists

Most Popular NASCAR Drivers

The Best Romance Movies of all Time

The Most Wanted Drug Lords

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!